150k Covid-19 vaccine doses procured from Zydus Cadila: Govt in Lok Sabha

A total of 150k Covid vaccine doses have been procured by the govt from Zydus Cadila at Rs 375.90 per jab (including GST), Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha

Zydus covid vaccine
Press Trust of India New Delhi
1 min read Last Updated : Dec 09 2022 | 6:51 PM IST

A total of 1.5 lakh Covid vaccine doses have been procured by the government from Zydus Cadila at Rs 375.90 per jab (including GST), Minister of State for Health Bharati Pravin Pawar informed the Lok Sabha on Friday.

As on December 5, 2022, a total of 102.54 crore first doses and a total of 95.09 crore second doses of COVID-19 vaccine have been administered. A total of 22.29 crore precaution doses have also been administered, Pawar said in a written reply.

She further said that 90 per cent of population aged 12 and above in the country have been covered by both doses of COVID-19 vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus Vaccinegovernment of India

First Published: Dec 09 2022 | 6:51 PM IST

Next Story